Frazier Life Sciences Management »

Dyne Therapeutics shares owned by Frazier Life Sciences Management

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Frazier Life Sciences Management from 13F filings

Historical chart of Frazier Life Sciences Management investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Frazier Life Sciences Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Frazier Life Sciences Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $16M 1.2M 13.30